| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.0M | +0.8% |
| Cost of Revenue | $14.4M | -1.3% |
| Gross Profit | $3.6M | +10.5% |
| R&D Expense | $200K | +0.0% |
| SG&A Expense | $3.4M | +13.4% |
| Operating Income | -$612K | -53.4% |
| Net Income | -$1.5M | -537.9% |
| EPS (Basic) | -$0.07 | -600.0% |
| EPS (Diluted) | -$0.07 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $220K | -76.1% |
| Accounts Receivable | $5.4M | +35.9% |
| Inventory | $8.5M | +9.0% |
| Current Assets | $14.5M | +11.6% |
| Total Assets | $25.6M | +48.3% |
| Current Liabilities | $11.4M | +12.5% |
| Total Liabilities | $14.9M | +10.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | -14.1% |
| Capital Expenditures | $331K | +49.8% |
| Investing Cash Flow | -$331K | -49.8% |
| Financing Cash Flow | $904K | -57.2% |
| Free Cash Flow | -$1.6M | -20.0% |
| -600.0% |
| Stockholders' Equity |
| $10.7M |
| +186.8% |